Importer of Controlled Substances; Notice of Application, 36680 [2010-15522]
Download as PDF
<![CDATA[
36680
Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices
Drug
Schedule
Morphine (9300) ...........................
II
The company plans to manufacture
the listed controlled substances as bulk
reagents for use in drug abuse testing.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than August 27, 2010.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
This is notice that on March 31, 2010,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the basic classes of controlled
substances listed in schedule II:
Schedule
jlentini on DSKJ8SOYB1PROD with NOTICES
21:02 Jun 25, 2010
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on April
20, 2010, United States Pharmacopeial
Convention, 12601 Twinbrook Parkway,
Rockville, Maryland 20852, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedules I and II:
II
II
Drug
The company imports the listed
controlled substances in order to bulk
manufacture controlled substances in
Active Pharmaceutical Ingredient (API)
form. The company distributes the
manufactured APIs in bulk form only to
its customers.
As explained in the Correction to
Notice of Application pertaining to
Rhodes Technologies, 72 FR 3417
(2007), comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
VerDate Mar<15>2010
[FR Doc. 2010–15522 Filed 6–25–10; 8:45 am]
Importer of Controlled Substances;
Notice of Application
[FR Doc. 2010–15516 Filed 6–25–10; 8:45 am]
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug
basic class of any controlled substances
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b),(c),(d),(e), and (f) are
satisfied.
Jkt 220001
Schedule
Cathinone (1235) ..........................
Methaqualone (2565) ...................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
4-Methyl-2,5-dimethoxy-amphetamine (7395).
3,4-Methylenedioxy amphetamine
(7400).
Codeine-N–Oxide (9053) .............
Heroin (9200) ...............................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Phencyclidine (7471) ....................
Alphaprodine (9010) .....................
Anileridine (9020) .........................
Cocaine (9041) .............................
PO 00000
Frm 00052
Fmt 4703
Sfmt 9990
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
Drug
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import
reference standards for sale to
researchers and analytical labs.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances may file comments or
objections to the issuance of the
proposed registration, and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 28, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–15519 Filed 6–25–10; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Page 36680]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-15522]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
This is notice that on March 31, 2010, Rhodes Technologies, 498
Washington Street, Coventry, Rhode Island 02816, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Raw Opium (9600)........................... II
Concentrate of Poppy Straw (9670).......... II
------------------------------------------------------------------------
The company imports the listed controlled substances in order to
bulk manufacture controlled substances in Active Pharmaceutical
Ingredient (API) form. The company distributes the manufactured APIs in
bulk form only to its customers.
As explained in the Correction to Notice of Application pertaining
to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for
hearings on applications to import narcotic raw material are not
appropriate.
As noted in a previous notice published in the Federal Register on
September 23, 1975, (40 FR 43745), all applicants for registration to
import a basic class of any controlled substances in schedule I or II
are, and will continue to be, required to demonstrate to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b),(c),(d),(e),
and (f) are satisfied.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-15522 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P
